Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 53.16B | 50.80B | 45.78B | 41.95B | 39.01B | 60.50B |
Gross Profit | 50.14B | 51.20B | 46.97B | 41.95B | 39.01B | 34.39B |
EBITDA | 22.39B | 22.22B | 19.64B | 18.23B | 16.87B | 734.00M |
Net Income | 13.35B | 12.57B | 11.08B | 9.61B | 8.12B | -8.77B |
Balance Sheet | ||||||
Total Assets | 1.82T | 1.84T | 1.80T | 1.73T | 1.60T | 1.51T |
Cash, Cash Equivalents and Short-Term Investments | 351.61B | 237.41B | 406.22B | 270.77B | 264.01B | 153.84B |
Total Debt | 311.96B | 483.38B | 310.98B | 282.96B | 249.02B | 235.27B |
Total Liabilities | 1.71T | 1.73T | 1.69T | 1.64T | 1.50T | 1.42T |
Stockholders Equity | 100.50B | 98.60B | 95.42B | 89.10B | 86.93B | 81.48B |
Cash Flow | ||||||
Free Cash Flow | 31.66B | -32.65B | 66.92B | 16.87B | 45.29B | 57.63B |
Operating Cash Flow | 38.62B | -24.16B | 80.56B | 27.71B | 56.69B | 66.15B |
Investing Cash Flow | -1.97B | -3.71B | -80.91B | -3.90B | -3.71B | -7.22B |
Financing Cash Flow | -9.39B | -5.51B | -2.06B | -9.96B | -1.32B | -1.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | €92.30B | 8.88 | 18.91% | 4.28% | 7.39% | 16.20% | |
73 Outperform | £127.72B | 9.71 | 13.10% | 1.94% | -14.67% | 16.25% | |
72 Outperform | €63.10B | 10.50 | 16.64% | 4.80% | -3.16% | 16.68% | |
71 Outperform | €5.91B | 9.49 | 9.57% | 6.84% | -5.30% | 55.66% | |
71 Outperform | €12.07B | 11.82 | 17.23% | 4.21% | -1.36% | 13.42% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |